Skip to content

Comparison of the Effect of Lidocaine-Morphine and Lidocaine-Ketamine Spray on Post-Tonsillectomy Pain

Comparison of the Effect of Lidocaine-Morphine and Lidocaine-Ketamine Spray on Post-Tonsillectomy Pain in Children

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014111019037N4
Enrollment
120
Registered
2014-11-17
Start date
2013-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain in throat (surgery site). Pain in throat

Interventions

Intervention 1: First intervention group: Local usage of handmade Lidocaine-Morphine spray (including Lidocaine 10% spray from Irandarou manufacturing company, Tehran, Iran, registered No. 1228129223
Treatment - Drugs
First intervention group: Local usage of handmade Lidocaine-Morphine spray (including Lidocaine 10% spray from Irandarou manufacturing company, Tehran, Iran, registered No. 1228129223 and Morphine 1
Second intervention group: Local usage of handmade Lidocaine-Ketamine spray (including Lidocaine 10% spray from Irandarou manufacturing company, Tehran, Iran, registered No. 1228129223 and Ketamine
Third intervention group: Local usage of handmade normal saline spray (including normal saline solution 9mg/ml from Daroupakhsh drug manufacturing company, Tehran, Iran, registered No. 1228057458): 1

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 6 to 12 years old children who are candidate for elective tonsillectomy. Exclusion criteria: Patients who usually use anticonvulsants or analgesics or anti-inflammatory agents; patients with history of allergy to morphine or lidocaine; patients with underline diseases like asthma.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post-operation pain. Timepoint: From the enterance to the recovery ward until one hour (every 20 minutes). Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026